Ancobon (Cardinal Health)


Welcome to the PulseAid listing for the Ancobon drug offered from Cardinal Health. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: flucytosine
SUBSTANCE NAME: FLUCYTOSINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1982-01-01
END MARKETING DATE: 0000-00-00


Ancobon HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAncobon from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 1982-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-6575_0c545593-e771-4f29-bcb1-fc0455146ac3
PRODUCT NDC: 55154-6575
APPLICATION NUMBER: NDA017001

Other FLUCYTOSINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalFlucytosine
Cameron Pharmaceuticals, LLCFlucytosine
Cardinal HealthAncobon
Carilion Materials ManagementFlucytosine
Rising Pharmaceuticals, Inc.Flucytosine
Valeant Pharmaceuticals North America LLCANCOBON
West-Ward Pharmaceuticals Corpflucytosine